<DOC>
	<DOCNO>NCT01900704</DOCNO>
	<brief_summary>To investigate efficacy safety SER120 nasal spray formulation patient nocturia</brief_summary>
	<brief_title>Multicenter Study Investigate SER120 Nasal Spray Formulations Patients With Nocturia - DB4</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male female 50 year old Nocturia 6 month duration average great 2 nocturic episode per night CHF Diabetis Insipidus Renal insufficiency Hepatic insufficiency Incontinence Illnesses require systemic steroid Malignancy within past 5 year Sleep apnea Nephrotic syndrome Unexplained pelvic mass Urinary bladder neurological dysfunction Urinary bladder surgery radiotherapy Pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>